The role of alveolar macrophages in the pathogenesis of recurrent airway obstruction in horses.
When challenged with allergens and pro-inflammatory agents, such as Aspergillus fumigatus (AF), hay dust solution (HDS) and lipopolysaccharide (LPS), the innate immune response will not only activate the immune system but also increase the amount of pro-inflammatory cytokines in the bronchoalveolar space. The aim of this study was to assess the response of equine alveolar macrophages to different aerosolized challenges and to investigate the differences in this response between horses susceptible or nonsusceptible to recurrent airway obstruction (RAO). Seven susceptible and 5 nonsusceptible horses were challenged with saline, LPS, HDS, or AF, and bronchoalveolar lavage (BAL) cytology, total cell counts, and lung function were assessed. In addition, alveolar macrophages were isolated 6 and 24 hours after challenge, and macrophage mRNA expression of tumor necrosis factor (TNF)-alpha and interleukins (IL) IL-1beta, IL-6, IL-8, and IL-10 were measured by means of real-time (RT) polymerase chain reaction (PCR). There was a significant difference in lung function, neutrophil ratios, and total cell counts in the bronchoalveolar lavage fluid between RAO-susceptible and nonsusceptible horses. In addition, the expression of TNF-alpha, IL-1beta, and IL-8 by alveolar macrophages after challenges were higher in susceptible horses, than in nonsusceptible horses. In contrast, I1-6, considered an anti-inflammatory cytokine, showed a higher expression in nonsusceptible horses 6 hours after inhalation challenge with allergens and pro-inflammatory antigens. These data suggest that the differences between susceptible and nonsusceptible horses to RAO are not only dependent on adaptive immunity but also start with an innate immune response.
Department of Equine Science, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. t.laan@delinge.hoeve.nl
Tamarinde T J M
TT
Laan
Sarah
S
Bull
R
R
Pirie
Johanna
J
Fink-Gremmels
D000818:Animals; D000946:Antigens, Fungal / Q000494:pharmacology; D001232:Aspergillus fumigatus; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D016207:Cytokines / Q000378:metabolism; D004391:Dust; D005260:Female; D005786:Gene Expression Regulation; D006734:Horse Diseases / Q000473:pathology* / Q000503:physiopathology*; D006736:Horses; D008070:Lipopolysaccharides / Q000494:pharmacology; D008173:Lung Diseases, Obstructive / Q000139:chemically induced / Q000503:physiopathology / Q000662:veterinary*; D016676:Macrophages, Alveolar / Q000378:metabolism*; D008297:Male
D000946:Antigens, Fungal; D016207:Cytokines; D004391:Dust; D008070:Lipopolysaccharides